We previously mined the Connectivity Map (CMap) database to explore the potential molecular target(s) of sorafenib and found that sorafenib indirectly inhibited HDAC activity in HCC cells [66]. The gene discussed is HDAC9; the disease is hepatocellular carcinoma.